Recombinant antibody production leverages Chinese hamster ovary (CHO) cells due to their efficiency in expressing complex proteins. Optimizing these processes involves modifying various parameters, including cell line development, media composition, and bioreactor settings. A key goal is to increase antibody yield while reducing production financia